varun TBRC’s Post

This morning we published our Q1 2024 earnings, and what a way to start the year. The report also marks a new era, as this was the first as a pure play orthobiologics company. Highlight from the report are: 💹 207% growth, both on reported and constant currency basis 💹 8th consecutive quarter of triple-digit growth in the U.S. 💹 93.7% gross margin, an increase of 23.3% year-on-year 💹 Major contracts won with Premier and VA, increasing access in the U.S 💹 Strong clinical data with 93% fusion rate in our TOP FUSION study In sum, we have started 2024 with another great performance where OssDsign Catalyst has been established in the elite class of high-performing synthetic bone grafts. Combined with a strong underlying growth in the market, an increasing elderly population driving future demand and the potential for broader use across orthopedic segments, we look forward to continuing building a fast-growing orthobiologics business that will create high shareholder value. Go OssDsign

𝐁𝐨𝐧𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 & 𝐓𝐫𝐞𝐧𝐝𝐬 2024-2031 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐃𝐞𝐦𝐨 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐄𝐱𝐜𝐞𝐥 𝐏𝐢𝐯𝐨𝐭 𝐚𝐧𝐝 𝐓𝐨𝐂: https://lnkd.in/ds46FY_2 The #BoneGrowthStimulator Market Size is valued at 1161.47 Million in 2023 and is predicted to reach 1967.46 Million by the year 2031 at a 7.04 % CAGR during the forecast period for 2024-2031. ▪ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐫𝐞: ▪Orthofix US LLC ▪Stryker ▪MEDICAL DEVICE BUSINESS SERVICES, INC. ▪Bioventus ▪Medtronic ▪DJO ▪Zimmer Biomet ▪Arthrex. ▪Terumo Medical Corporation ▪Ossatec BeNeLux BV #BoneHealing #MarketAnalysis #OrthopedicDevices #BoneMorphogeneticProteins #PRP

Suture Anchor Devices Market is projected to reach USD 1.02 billion by 2030 According to Regional Research Reports, "the Global #Suture_Anchor_Devices_Market is projected to reach USD 1.02 billion by 2030 from USD 670.35 million in 2021, growing at a CAGR of 4.60% from 2022 to 2030". The report explains that this business is estimated to register a remarkable growth rate over the upcoming period. This report provides comprehensive market estimation information concern to the total valuation that is presently accounted for by this industry and it also includes segmentation, companies’ analysis along with the growth opportunities and trends present across this business application. This report also provides the effect of the recession, Inflation on the market, sanctions, and trade war between various countries. #Suture_anchor_devices specifically designed for #particular_tissues, such as cartilage, tendons, or ligaments. These devices improve #surgical results by considering the tissues' special biomechanical characteristics and healing needs. Visit For More Information: https://lnkd.in/d9ypJv2e Major companies and vendors included in the Suture Anchor Devices Market are: Smith & Nephew Group Plc. Zimmer Biomet Holdings, CONMED Corporation Arthrex. Johnson & Johnson (DePuy Synthes, Inc.) Medtronic Stryker Wright Medical Group N.V. Teknimed MedShape, Inc. South America Implants Anstem Medical Groupe Lépine In2Bones International TULPAR TIBBİ ÜRÜNLER - TULPAR MEDICAL SOLUTIONS Biocomposites HNM Medical Surgical Frontiers

Surgical Drill Characteristics A surgical drill is a specialized medical instrument designed for cutting, drilling, or creating holes in bone or hard tissues during surgical procedures. These precision instruments are crucial in orthopedics, neurosurgery, dentistry, and other medical fields. The surgical drill market has grown significantly, expanding from $1.15 billion in 2023 to $1.23 billion in 2024 (CAGR: 7.0%). It is projected to reach $1.55 billion by 2028 (CAGR: 6.0%). Key Players Medtronic, Stryker, Zimmer Biomet, Arthrex., CONMED Corporation The surgical drill market is experiencing robust growth driven by advancements in healthcare technology, increased demand for surgical procedures, and rising healthcare expenditures. However, the market faces significant challenges related to sterilization and quality assurance. Future trends indicate a continued focus on minimally invasive procedures, enhanced ergonomics, and investment in research and development to improve patient outcomes and surgical efficiency. Read more https://lnkd.in/gvmByCGm #SurgicalDrills #MarketGrowth #HealthcareAdvancements #AestheticSurgeryDemand #QualityAssurance #FutureTrends #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC

𝗘𝘅𝘁𝗲𝗿𝗻𝗮𝗹 𝗙𝗶𝘅𝗮𝘁𝗼𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 *𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗥𝗲𝗽𝗼𝗿𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/ewvjkPxV This report provides an overview of the global market for external fixators, including sales, revenue, and pricing trends. It analyzes market trends with historic revenue and sales data from 2019 to 2023, estimates for 2024, and projections of the compound annual growth rate (CAGR) through 2030. The report focuses on key producers, their sales in major regions and countries such as the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries. It identifies major stakeholders in the global external fixator market and examines their competitive landscape and market positioning based on recent developments and segmental revenues. This information aims to help stakeholders understand the competitive environment, gain insights, and better position their businesses and market strategies. *𝗕𝘆 𝗧𝘆𝗽𝗲: Cycle, Unilateral, Mixing *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals, Ambulatory Surgery Centres *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: DePuy Synthes, Stryker, Zimmer Biomet, Smith+Nephew, Accumed, Arthrex, B. Braun Group, Cardinal Health, Citieffe, CONMED Corporation, Double Medical Technology Inc., Integra LifeSciences, Medtronic, Orthofix, Wright Medical #ExternalFixator #OrthopedicSurgery #BoneFracture #FractureTreatment #OrthopedicImplant #MedicalDevice #Stabilization #Immobilization #CAGR #MarketAnalysis #GlobalMarket #SalesRevenue #KeyProducers #CompetitiveLandscape #Healthcare #MedicalTechnology #OrthopedicInnovation #Recovery #PatientCare #MarketTrends

Regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) has chalked up record revenue of A$2.03 million for the September 2024 quarter, marking a second consecutive quarter of record growth. The figures are a 7.82% increase on the A$1.88 million achieved in the June quarter, driven by growing demand for its market-leading flagship assets, Striate+™ and Remplir™. Striate+, used for dental bone regeneration, is currently sold in key global markets, including the US, Canada, Europe, the UK, Australia and New Zealand. Remplir, a product designed for peripheral nerve repair, is available in Australia and New Zealand, with further international expansion planned. As a result of their strong clinical performance, both products are seeing increasing uptake among surgeons. Orthocell is targeting new regulatory approvals to expand into additional markets. More at #Proactive #ProactiveInvestors #ASX #OCC #Biotech #Medtech #RegenerativeMedicine http://ow.ly/n9i4105L9e7

[Sent with Free Plan] Osteopore Limited (ASX: OSX), a trailblazer in 3D-printed biomimetic and bioresorbable implants, has signed an Exclusive Distribution Agreement with medical technology giant Zimmer Biomet. The agreement will see Zimmer Biomet, a company ranked 19th among the top 100 medical device companies globally, distribute Osteopore's craniofacial products across 24 countries in Europe, the Middle East, and Africa (EMEA), and the Asia Pacific (APAC), including Australia and New Zealand. This multi-year agreement positions Osteopore to capitalize on the USD $53.4 million global craniofacial implant market, which is projected to grow to $118.2 million by 2032 at a CAGR of 8.3%. Osteopore's CEO, Dr. Yujing Lim, highlighted that this partnership aligns with the company's strategic goals, leveraging Zimmer Biomet's extensive sales, marketing capabilities, expertise, and network to significantly boost market reach and presence in the EMEA and APAC regions. The agreement includes minimum purchase commitments and stocking orders, ensuring Osteopore retains control over its intellectual property, encompassing any modifications and improvements, thereby solidifying their market position. As the medical field's focus increasingly shifts toward regenerative medicine and natural healing, Osteopore's pioneering products stand to meet growing clinical demands effectively. Overall, this partnership marks a pivotal advancement in Osteopore's commercial journey, doubling their presence in the EMEA region and strengthening their footprint in the lucrative global craniofacial implant market.

𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐖𝐨𝐫𝐭𝐡 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟗.4 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭- https://lnkd.in/d9MUqDJq The global electrosurgery market in terms of revenue was estimated to be worth $6.9 billion in 2024 and is poised to reach $9.4 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029. 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 Medtronic Plc Johnson & Johnson Olympus Corporation B. Braun Group CONMED Corporation Boston Scientific Smith+Nephew Erbe Elektromedizin GmbH Stryker BOWA-electronic KG THE COOPER COMPANIES GLOBAL HOLDINGS LP Kirwan Surgical Products LLC Zimmer Biomet Utah Medical Products, Inc. Integra LifeSciences Holdings SAS Encision KLS Martin Group Surgical Holdings I.C. Medical Meyer-Haake GmbH - Medical Innovations Aspen Surgical Applied Medical Resources Apyx Medical DirectaDentalGroup

SpeedPearl: Osteochondral Allografts—Orthobiologic Application Brian J. Cole, MD, MBA (Chicago, IL), discusses the benefits of using orthobiologic products during osteochondral allograft procedures to support graft incorporation with a goal of decreasing cystic changes. #Arthrex #FoundationMedical #OrthoBiologics #Allograft #Innovation

#Augmented_Bone_Graft Market size of nearly USD 5.76 Billion by 2032 from USD 3.01 Billion in 2023 with a CAGR of 7.5% under the study period 2024-2032. https://lnkd.in/gRjeTnSP Advances in biotechnology and #material science drive the augmented bone graft market and have led to the #development of enhanced graft materials that improve #bone regeneration and healing. The increasing prevalence of orthopedic conditions, such as fractures, #bone defects, and degenerative diseases, significantly #boosts the market growth. Medtronic Medtronic CEMA DePuy Synthes Zimmer Biomet Zimmer Group STRYKER SALES CORPORATION Straumann Group RTI Surgical® Wright Medical Geistlich Pharma Xtant Medical Arthrex